Last month, the FDA officially ended the shortage designation for GLP-1 medications, including Ozempic and Wegovy.
Tag:
GLP-1
-
-
-
(GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported today
